Both have decades of clinical use behind them, which provides a level of evidence that newer peptides like Dihexa and P21 have not yet achieved despite their promising preclinical results
While much of the early research on BPC-157 has been conducted through injectable administration in animal models, interest in oral administration has grown significantly due to its convenience and ease of use
Switching From Semaglutide or Tirzepatide A year or more of tirzepatide use builds tolerance to GIP and GLP-1 signaling but not to retatrutides glucagon arm
Peptide Therapy at a Glance EXPECTED RESULTS Enhanced cellular repair, improved hormone balance, increased energy, better sleep, fat loss, and immune support TREATMENT LENGTH Varies daily or weekly administration over 412+ weeks depending on protocol RECOMMENDED SESSIONS Ongoing use for 13 months, with regular monitoring and dose adjustments WHERE IT TREATS Systemic works at the cellular level to support immune, endocrine, metabolic, and neurological systems WHAT IT TREATS Hormone imbalance, weight gain, poor recovery, fatigue, inflammation, aging, low libido, immune dysfunction, and neurological decline TREATMENT COST $350 $1,200/month (depending on the type of peptide and dosing protocol) What is Peptide Therapy
Link United States Anti-Doping Agency (USADA)
Studies show 60-80% faster healing with BPC-157 treatment versus controls